Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking a double dose of Mounjaro by accident is more common than people assume, and the honest answer is: it can intensify side effects significantly, but it is rarely a medical emergency. If you have just realised you have taken two doses of tirzepatide in quick succession, stop, put the pen down, and read on — this page covers what the evidence says, what symptoms to watch for, and when to call for help. Mounjaro is a prescription-only medicine; your prescriber and the Patient Information Leaflet are the right guides for your specific situation, and our aftercare team is available seven days a week if you are treated through nume.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people who have accidentally taken two doses worry mainly about harm, which is the right instinct. But there is a separate misconception worth addressing, that a larger-than-prescribed amount of tirzepatide might accelerate results. It will not. Mounjaro works by activating GIP and GLP-1 receptors involved in appetite signalling and gastric emptying; doubling the dose does not double the effect on those pathways. What it does is flood your system with more drug than your body is calibrated for at that moment, which means the side effects the titration schedule is specifically designed to ease through gradually arrive all at once.
The tirzepatide titration schedule starts at 2.5mg precisely because the body needs time to adjust. Taking twice the intended weekly amount bypasses that buffer. The NHS notes that nausea, vomiting, diarrhoea and indigestion are the most commonly reported effects of tirzepatide, and any of these can intensify sharply when the dose is higher than prescribed. You can read the full side-effect profile on the NHS tirzepatide medicines page. The key point: more drug, in this case, produces more discomfort, not more benefit.
If you are someone who has doubled a dose deliberately because progress has felt slow, that feeling is understandable. But the decision to increase a dose belongs to your prescriber alone, who will want to see evidence that the current dose is well tolerated before moving up.
Tirzepatide is a once-weekly subcutaneous injection that stays active in the body for several days after each dose. When a second pen is used too soon, the concentration of the drug in your bloodstream rises above the level that was agreed and titrated. The practical consequences depend on your current dose strength and your individual tolerance, but the pattern is predictable.
Gastrointestinal effects are the most likely immediate experience: nausea that may arrive within hours, vomiting, loose stools, or a cramping feeling in the abdomen. Gastric emptying slows more than usual, so food sitting heavily in the stomach is common. Some people also report fatigue, dizziness, or a low appetite that is more pronounced than normal. These effects are uncomfortable but typically self-limiting, they ease as the excess drug is metabolised over the following days.
The symptom that requires urgent attention is different in character: severe, persistent abdominal pain that does not settle and may radiate through to the back, with or without vomiting. In January 2026, the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines, you can report any suspected serious reaction through the MHRA Yellow Card scheme. This kind of pain is the threshold for calling 111 or going to A&E rather than waiting it out.
Dehydration is also a real risk if vomiting or diarrhoea is severe. Keep sipping plain water and, if you cannot keep fluids down for several hours, that too is a reason to seek medical advice.
First, do not take another dose to try to reset the schedule. If you accidentally took two doses this week, your next weekly injection should simply be skipped so the gap between doses returns to seven days from the accidental double. Some people consider halving the following week's dose to compensate; do not do this without speaking to a prescriber first, because Mounjaro pens are pre-set and altering them is not safe or practical.
If you are unsure whether you actually took two doses (perhaps you could not remember if you had already injected) the guidance from prescribers is generally to treat it as a missed dose rather than a double one and proceed normally. The page on what to do after a missed Mounjaro dose covers that scenario in detail. Similarly, if you are wondering whether it is safer to skip a week altogether after the accident, the effects of skipping a full week are worth reading before deciding.
Practically: stay hydrated, eat very light and plain food if you feel sick, rest, and monitor your symptoms. If you want a clearer picture of what happens if you take 2 doses of Mounjaro, including the likely timeline of effects, that page brings together the key detail in one place. You may also find it useful to read about what happens if you take two doses of Mounjaro, which addresses the question from a more personal perspective and covers what to monitor in the hours that follow. Write down the time of both doses if you can, your prescriber will want to know this. If you are a nume patient and have any concern at all, the aftercare team can connect you with a prescriber the same day.
For most people who have doubled a lower dose (2.5mg or 5mg) the experience is unpleasant but manageable at home. The threshold for contacting a clinician shifts if: the symptoms are severe or worsening after several hours rather than settling; you have a history of pancreatitis or gallbladder problems; you are also taking other medications that might interact; or the affected person has type 2 diabetes and is also on insulin or a sulfonylurea, where blood sugar changes can compound things.
A question our prescribers hear regularly is whether the accidental dose means the whole titration schedule needs to be reset. Usually it does not, a single accidental double dose, once recovered from, allows a return to the normal weekly injection at the correct strength. However, if the double dose caused a significant adverse reaction, your prescriber might want to hold at the current strength for an extra week before any planned increase. For those who are thinking about what happens when doses go up deliberately rather than accidentally, the page on starting at 5mg gives context on how titration decisions are made.
Mounjaro is a prescription-only medicine, and the cost and effort involved in getting it through a properly regulated service reflects the clinical oversight you receive alongside it. If you are considering treatment and want that oversight from the start, you can start your free consultation with our GPhC-registered prescribers, who review every case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.